Karl Ronn

Karl Ronn is currently an advisor at Amae Health. Prior to that, they were with First Mile Care and Innovation Portfolio Partners LLC. From January 2001 to December 2010, Karl was with Procter & Gamble where they were the VP Research & Development and GM New Business Health Care. During their time there, they oversaw brands such as Vicks, Prilosec, Align, Pepto Bismol, Metamucil, Actonel, and Swiss Precision Diagnostics (a joint venture with Alere).

Karl Ronn earned their Bachelor of Science in Chemical Engineering from The University of Toledo.